Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,13 CAD | +4,00% | -7,14% | +62,50% |
Omzet 2022 | 2,67 mln. 1,94 mln. 1,82 mln. | Omzet 2023 | 149K 108K 102K | Marktkapitalisatie | 10,55 mln. 7,66 mln. 7,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -3 mln. -2,18 mln. -2,05 mln. | Nettowinst (verlies) 2023 | -5 mln. -3,63 mln. -3,41 mln. | EV/omzet 2022 | 6,37 x |
Nettoschuld 2022 | 5,76 mln. 4,18 mln. 3,93 mln. | Nettoschuld 2023 | 8,51 mln. 6,18 mln. 5,8 mln. | EV/omzet 2023 | 128 x |
K/w-verhouding 2022 |
-2,79
x | K/w-verhouding 2023 |
-2,02
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 63,55% |
Recentste transcriptie over Kane Biotech Inc.
1 dag | +4,00% | ||
1 week | -7,14% | ||
Lopende maand | +30,00% | ||
1 maand | +23,81% | ||
3 maanden | +52,94% | ||
6 maanden | +85,71% | ||
Lopend jaar | +62,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 02-06-16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 05-09-17 |
Compliance Officer | - | 12-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 15-09-10 |
Chairman | 59 | 20/02 | |
Georges Morin
BRD | Director/Board Member | - | 20-05-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,13 | +4,00% | 3 000 |
17-04-24 | 0,125 | -10,71% | 2 074 000 |
16-04-24 | 0,14 | +3,70% | 90 000 |
15-04-24 | 0,135 | +8,00% | 1 936 001 |
12-04-24 | 0,125 | -10,71% | 192 000 |
uitgestelde koers Toronto S.E., 18 april 2024 om 15:40 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+62,50% | 11,94 mln. | |
-1,63% | 41,36 mld. | |
+44,25% | 41,3 mld. | |
+2,80% | 39,61 mld. | |
-15,14% | 25,62 mld. | |
+3,73% | 24,09 mld. | |
-24,15% | 18,38 mld. | |
+23,56% | 11,85 mld. | |
-2,81% | 11,82 mld. | |
+8,13% | 11,07 mld. |